Ovarian cancer in obese women: risk and optimal medical and surgical treatment options

Samir A Farghaly

doi:10.2217/whe.15.16

Ovarian cancer in obese women: risk and optimal medical and surgical treatment options

Womens Health (Lond). 2015 Jun;11(3):261-3. doi: 10.2217/whe.15.16.

Author

Samir A Farghaly¹

Affiliation

¹ The Joan & Sanford I. Weill Medical College, & The New York Presbyterian Hospital/Weill Cornell Medical Center, Cornell University, 525 East 68 Street, P713A, NY, USA.

PMID: 26102463
DOI: 10.2217/whe.15.16

No abstract available

Keywords: IGFBP-2; cancer chemotherapy; disease-free survival; leptin; obese women; ovarian cancer; ovarian cancer survival rate; overall survival; robot-assisted surgery; supraradical cytoreduction.

Publication types

Editorial

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Combined Modality Therapy / methods
Female
Humans
Obesity / complications*
Ovarian Neoplasms / complications*
Ovarian Neoplasms / drug therapy
Ovarian Neoplasms / pathology
Ovarian Neoplasms / surgery*
Ovariectomy
Risk Factors
Survival Analysis
Tumor Burden
Women's Health*